Author

Parwana Hussaini

Institutions: Oslo University Hospital, University of Oslo

Observed institutions: Oslo University Hospital, University of Oslo

ORCID: 0009-0001-0007-7943

Observed ORCID: 0009-0001-0007-7943

OpenAlex ID: A5000479422

Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism

2023 · Parwana Hussaini, Trine-Lise Larsen, et al. · Thrombosis and Haemostasis · 7

Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban

2026 · Parwana Hussaini, Trine-Lise Larsen, et al. · Research and Practice in Thrombosis and Haemostasis

Po37 | Clinical Significance of Symptomatic and Incidental Venous Thromboembolism in Cancer Patients Treated With Apixaban

2026 · Parwana Hussaini · DOAJ (DOAJ: Directory of Open Access Journals)

Bleedings in Cancer Patients Treated with Apixaban for Venous Thromboembolism

2022 · Parwana Hussaini, Trine-Lise Larsen, et al. · Blood

Works count: 4

Citation count: 7

H-index: 1

I10-index: